a place for your medical questions answered correctly. Please consult a doctor or a medical clinic before using any of the information present on this page. More often than not, we just do not have time or shy away from visiting a doctor than anything else that comes in the way of taking proper precautions and timely steps for some health related problems. We offer free medical information and medical help.You will find medical questions asked by people like you and answers to them.
Saturday, September 26, 2015
DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/zqmxdj/the)
has announced the addition of the "The
Pharmaceutical Market: Vietnam" report to their offering.
Corruption will continue to affect Vietnam s pharmaceutical and
healthcare business environment and potentially delay the introduction
of universal healthcare coverage for its people.
While corruption is a clear downside risk, we maintain that the sector
still offers strong growth opportunities for foreign investors.
Competitive Landscape:
The competitive landscape section provides comparative company analyses
and rankings by US$ sales and % share of total sales - for the total
pharmaceutical sector, as well as the OTC, generics, and distribution
sub-sectors.
Key Topics Covered:
1. Buy Allegra (Fexofenadine Hcl) with no Rx SWOT
2. About Yasmin (Drospirenone - Ethinyl Estradiol) Political
3. About Levitra Pack-60 () with free prescription Economic
4. Buy Fluticasone Business Environment
5. About Imuran (Azathioprine) Industry Forecast
6. Buy Cornsilk online Pharmaceutical Market Forecast
7. http://cardiobloodreview.wordpress.com Healthcare Market Forecast
8. Prescription Drug Market Forecast
9. Patented Drug Market Forecast
10. Generic Drug Market Forecast
11. OTC Medicine Market Forecast
12. Pharmaceutical Trade Forecast
13. Other Healthcare Data
14. Key Risks To The Forecast Scenario
15. Macroeconomic Forecasts
16. Economic Analysis
- Table: Economic Activity (Vietnam 2009-2018)
17. Industry Risk Reward Ratings
18. Asia Pacific Risk/Reward Ratings
19. Vietnam Risk/Reward Ratings
20. Rewards
21. Risks
22. Market Overview
23. Industry Trends And Developments
24. Epidemiology
25. Healthcare Financing
26. Hospital Sector
27. Private Healthcare Sector
28. Healthcare Insurance
29. Healthcare And Pharmaceutical Reform
30. Research And Development
31. Biotechnology Sector
32. Clinical Trials
33. Regulatory Development
34. Regulatory Regime
35. Pharmaceutical Advertising
Companies Mentioned
- DHG Pharmaceutical
- GlaxoSmithKline
- Merck & Co
- Novartis
- Pfizer
- Sanofi
- Traphaco Pharmaceutical
- Vidipha Central Pharmaceutical Joint Stock Company
- Vietnam OPV Pharmaceutical Co
- Vietnam Pharmaceutical Corporation (Vinapharm)
- Vietnam Pharmaceutical Joint Stock Company (Ampharco)
For more information visit .researchandmarkets.com/research/zqmxdj/the
About Research and Markets
Research and Markets is the world s leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
Friday, September 11, 2015
Samenvatting FDA geeft beoordeling Takeda’s ixazomib tegen ziekte van Kahler prioriteit
. Buy Celery Seed online CAMBRIDGE, Mass. http://doctor-answers.blogspot.com/ About Zyloprim (Allopurinol Bp) & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited heeft vandaag bekendgemaakt dat de
Amerikaanse Food and Drug Administration (FDA) de vergunningsaanvraag
voor ixazomib een prioriteitsstatus heeft verleend. Aygestin (Norethisterone Bp) Ixazomib is de
eerste experimentele, oraal in te nemen inhibitor voor de behandeling
van teruggekeerde of hardnekkige ziekte van Kahler (multipel myeloom)
“Het motiveert ons enorm van dat toezichthouders van de Verenigde
Starten en Europa hebben vastgesteld dat de aanvragen voor ixazomib
voldoen aan de criteria voor een versnelde beoordeling, wat het belang
van nieuwe behandelopties voor pati"enten met hardnekkig of teruggekeerd
multipel myeloom onderstreept”, zei Melody Brown, vicevoorzitter van de
afdeling voor regelgeving van Takeda. Inderal (Propranolol) with free Rx “Ons programma voor ixazomib is
ontwikkeld om te onderzoeken of een therapie met een proteasoominhibitor
de resultaten van een pati"enten met de ziekte van Kahler verbetert. Femilon with free prescription Er
bestaat een grote medische behoefte op gebied van multipel myeloom en we
kijken ernaar uit samen te werken met de toezichthouder zodat we
ixazomib naar de pati"ent kunnen brengen.”
Deze bekendmaking is officieel geldend in de originele brontaal. Buy Man XL () without Rx
Vertalingen zijn slechts als leeshulp bedoeld en moeten worden
vergeleken met de tekst in de brontaal, welke als enige rechtsgeldig is.
Wednesday, September 2, 2015
Botulism Therapeutics Pipeline Review, H2 2015 - 4 Companies & 7 Drug Profiles
. Buy Brewer’s Yeast online Buy Motrin (Ibuprofen) with no Rx DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/4fgmkz/botulism)
has announced the addition of the "Botulism
- Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Botulism, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. http://medical-reviews.blogspot.com About Eulexin with free prescription Buy Viagra (Sildenafil Citrate) with no Rx It also reviews
key players involved in the therapeutic development for Botulism and
special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. Buy Nizoral (Ketoconazole) without prescription Buy Cialis (Tadalafil) with free prescription It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
AlphaVax, Inc.
Hawaii Biotech, Inc.
Molecular Targeting Technologies, Inc.
XOMA Corporation
Drug Profiles
BoNT/A HcR4
botulinum vaccine
botulism vaccine
Monoclonal Antibodies to Inhibit Botulinum Neurotoxin for Botulism
Recombinant Peptides to Inhibit Botulinum Toxin for Botulism
Small Molecules for Botulism
XOMA-3-AB
For more information visit .researchandmarkets.com/research/4fgmkz/botulism
Subscribe to:
Posts (Atom)